2 imaging AI vendors teaming up to present 1 point of sale

A healthcare AI platform supplier headquartered in Scotland is collaborating on marketing with a San Francisco-based AI startup co-founded and -led by a radiologist.

Blackford Analysis and Rad AI jointly announced their strategic sales partnership June 22.

The alliance will allow Blackford to sell Rad AI’s report customization capabilities alongside Blackford’s own offerings for integrating AI into radiologists’ workflows.

Rad AI “automatically generates a customized impression from the findings and clinical indication dictated by the radiologist, using the most advanced neural networks,” the companies explain. “It learns each radiologist’s language preferences from their prior reports, to create an impression that the radiologist can simply review and finalize.”

Radiologist Jeff Chang, MD, Rad AI’s co-founder and chief product officer, says the two companies share the goal of improving efficiency and reducing burnout in radiology practices.

Blackford founder and CEO Ben Panter says radiology “has never been under more pressure, and we believe that harnessing AI makes a real difference.”

Blackford’s corporate offices are in Edinburgh, Rad AI’s in Lafayette, Calif.

Full announcement here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.